Stifel Financial’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,607
| Closed | -$337K | – | 3495 |
|
|
2024
Q3 | $337K | Buy |
+7,607
| New | +$337K | ﹤0.01% | 2898 |
|
|
2024
Q2 | – | Sell |
-8,860
| Closed | -$382K | – | 3461 |
|
|
2024
Q1 | $382K | Sell |
8,860
-1,950
| -18% | -$84.1K | ﹤0.01% | 2760 |
|
|
2023
Q4 | $450K | Buy |
+10,810
| New | +$450K | ﹤0.01% | 2623 |
|
|
2023
Q3 | – | Sell |
-6,159
| Closed | -$252K | – | 3416 |
|
|
2023
Q2 | $252K | Sell |
6,159
-15,448
| -71% | -$633K | ﹤0.01% | 2929 |
|
|
2023
Q1 | $886K | Sell |
21,607
-380
| -2% | -$15.6K | ﹤0.01% | 2140 |
|
|
2022
Q4 | $900K | Buy |
+21,987
| New | +$900K | ﹤0.01% | 2079 |
|
|
2022
Q1 | – | Sell |
-16,757
| Closed | -$773K | – | 3510 |
|
|
2021
Q4 | $773K | Sell |
16,757
-7,006
| -29% | -$323K | ﹤0.01% | 2307 |
|
|
2021
Q3 | $1.13M | Buy |
23,763
+702
| +3% | +$33.3K | ﹤0.01% | 1998 |
|
|
2021
Q2 | $1.19M | Buy |
23,061
+746
| +3% | +$38.6K | ﹤0.01% | 1965 |
|
|
2021
Q1 | $1.12M | Sell |
22,315
-2,174
| -9% | -$110K | ﹤0.01% | 1917 |
|
|
2020
Q4 | $1.28M | Buy |
24,489
+376
| +2% | +$19.6K | ﹤0.01% | 1671 |
|
|
2020
Q3 | $1.05M | Buy |
24,113
+11,495
| +91% | +$500K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $542K | Buy |
+12,618
| New | +$542K | ﹤0.01% | 1989 |
|
|
2016
Q1 | – | Sell |
-4,113
| Closed | -$210K | – | 2395 |
|
|
2015
Q4 | $210K | Sell |
4,113
-12,852
| -76% | -$656K | ﹤0.01% | 2095 |
|
|
2015
Q3 | $795K | Sell |
16,965
-377
| -2% | -$17.7K | ﹤0.01% | 1318 |
|
|
2015
Q2 | $1.08M | Buy |
17,342
+7,576
| +78% | +$472K | 0.01% | 1324 |
|
|
2015
Q1 | $603K | Buy |
9,766
+538
| +6% | +$33.2K | ﹤0.01% | 1529 |
|
|
2014
Q4 | $498K | Buy |
9,228
+610
| +7% | +$32.9K | ﹤0.01% | 1612 |
|
|
2014
Q3 | $457K | Sell |
8,618
-542
| -6% | -$28.7K | ﹤0.01% | 1583 |
|
|
2014
Q2 | $475K | Sell |
9,160
-7,942
| -46% | -$412K | ﹤0.01% | 1520 |
|
|
2014
Q1 | $800K | Buy |
+17,102
| New | +$800K | 0.01% | 1186 |
|